What makes us different from other trading websites and investment newsletters?
Value. Your monthly subscription costs about as much as you pay your broker for one or two option trades.
Accountability. Unlike other sites, we don't just drop trades and walk away. Phil Davis, David Ristau and Optrader are on-line most trading days to talk to you live. How's that for backing up our trade ideas? We follow our trades through from open to close and we're there for you to help analyze your own trades and look for ways to improve them.
Exclusivity. You can’t make trades with 10,000 other people – it just doesn’t work! We limit our membership to give everyone a chance to pick up the positions we spot.
Community. Come for the great calls…stay for the great conversation. Our active daily forum is unique – no other investment newsletter or trading service has such a busy community of informed members offering their own opinions, ideas, and input.
Phil is often an active participant, not just a name on the marquee. If you’re an amateur or professional trader, you’ll find that our members are some of the smartest and most experienced around. No matter who you are, you’ll benefit from the dialogue our subscribers have with each other every single day.
A message from Phil:
There’s nothing I hate more than people who tell you what you would have made if you had done some perfect entry and perfect exit on a trade they vaguely recommended out of dozens that didn’t work out. It’s never going to happen here!
We keep a running archive of every single post and ever single trade idea since November of 2005 so you can see for yourself what you think of our picks! Do I need your credit card so you can look? No, why should I – the work should stand on their own. If you think they would have helped you in the past then you may decide on your own whether you want to sign up for our daily live site.
How can we give all that away for free? Because our performance is not a fluke, we do this all the time and we’re pretty sure there will be brand new trading opportunities for us tomorrow – the old ideas you can keep with our compliments!
This is not your run-of-the-mill dry, financial reporting! According to Google, there are 11,500,000 stock picking pages on the web and they all think they’re smarter than us… We don’t try to out shout the masses – we just try to have some fun and make some money! Now I’ve been told by marketing experts that I need to put in giant letters that say we make more trades, more often than most newsletters (we do), that I should make a big deal about how we try to pick real, well-known companies that are fairly liquid so you can get your money in and (more importantly) out and I’m supposed to make a big deal about beating the markets month after month (we do). I’m not going to do that…
When I used to look for a financial newsletter I would always read that stuff and go “blah blah blah” in my head until I found some kind of sample of the actual trading. Well, we give you full access to our posted trade ideas and, when you sign up for a FREE trial of the PSW report, you can even view EVERY SINGLE comment and trade idea in our premium member chat from the past 7-30 days. All the winners and all the losers, not just selected “samples”. There’s also a weekly update free, right on this site and you can take a look most Fridays or Saturdays for yourself and you can check out my style for yourself and decide if it would annoy or please you to read me every day.
All right, so I’m not good at marketing – but that’s not why you’re here is it? I am an amateur investor, like you, who just got sick of all the BS I was getting from all the “professional” services and I decided to start my own. I’m not a broker or a pro trader and you would be nuts to make any trade you read about here without consulting a professional financial advisor as to its suitability for your virtual portfolio… But, if you like to talk about stocks and pick up some tips that might work without all the hype and nonsense – come join us!
So why listen to me? I do have sort of a knack for spotting trends and picking winners and I’m happy to share what I know with you. No other reason. Nothing bad will happen to you if you don’t sign up with us – there is no pressure and this is not a limited offer. Come back any time we are accepting new members – the door will always be open. Looking forward to meeting you, – Phil
The market went through some gyrations on Wednesday in reaction to Fed Chairman Bernanke’s testimony before the Joint Economic Committee. He first defended continued quant easing by warning, “A premature tightening of monetary policy could lead interest rates to rise temporarily but also would carry a substantial risk of slowing or ending the economic recovery.” Stocks dutifully rallied and all major indexes hit new intraday highs.
But alas, consensus is apparently not a given over the longer term. The minutes hinted that a tapering off could start sooner, “A number of participants expressed willingness to adjust the flow of purchases downward as early as the June meeting if the economic information received by that time showed evidence of sufficiently strong and sustained growth.” So …...
UPDATE: They are paniccing... BOJ injected 2 trillion yen ($19.4 billion) into the financial system to stem volatility following a circuit breaker in JGB futures trading.
All the time it is just the quadrillion JPY second-largest bond market in the world that is experiencing volatility on an unprecedented scale, the BoJ and her partners in crime are more than willing to 'officially' say "please do not worry." But when the equity market - that barometer of everything good and holy about Abenomics starts to crater, you can bet the excuses will co...
Few stocks have attracted more news over the last six months than nutritional supplement maker Herbalife (NYSE: HLF).
Even casual market observers are aware of the circumstances surrounding the the initial bout of extreme volatility in the name back in December 2012. The shares went into free-fall at the end of the year after hedge fund manager Bill Ackman revealed in typical sanctimonious fashion that his firm Pershing Square Capital Management was short around $1 billion worth of the stock.
Amid much pomp and circumstance, Ackman laid out his short thesis at a New York investment conference and...
SKS - Saks, Inc. – Timely bullish bets initiated in Saks options just seconds prior to the closing bell on Tuesday are generating sizable gains for at least one trader today, with shares in the high-end retailer up at the highest level since 2008. The stock closed Tuesday up 11% on the day at $13.67 after the company reported first-quarter revenue above average analyst expectations. Within minutes of the close shares in SKS moved sharply to the upside after the New York Post, citing a source familiar with the matter, reported...
With yesterday's dovish duo Bullard and Dudley to set expectations, the S&P 500 rallied in anticipation of Chairman Bernanke's congressional testimony and soared to its all-time intraday high, up 1.07% during his prepared remarks. But the Q&A deflated the balloon, and the 2 PM release of the latest Fed Minutes accelerated the decline. It seems that the possibility of tapering QE in the near term is not entirely off the table. The index hit its -1.23% intraday low about 30 minutes before the final bell. It then trimmed its loss to close down 0.83%. The 10-year yield jumped 9 bps to close at 2.03%, just off the 2013 interim high of 2.07% on March 11th and 37 bps off its 2013 low set 14 sessions back.
Here is a 15-minute look at the week so far.
Not surprisingly the volume on today's 2.32% high-low intraday range was 24% above its 50-day movi...
Doing a lot of data mining as we watch this market go parabolic.
The S&P 500 is 13.4% over the 200 day moving average. 10%+ is considered overbought, and 12% is very rare.
The current Relative Strength Index (RSI) on the S&P 500 is 75. Over 70 is generally overbought (below 30 oversold). To put in perspective in 1999 the S&P touched 70ish a few times but never hit 75. The NASDAQ in 1999 – early 2000 hit mid 70s a few days in July 99 and Mar 00. Then in the parabolic move in November and December 1999 (NASDAQ gained over 1000 pts!) it sat between 70 and mid 80s for most of two months; of course t...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Reminder: Craigzooka is available to chat with Members regarding his virtual portfolio performance, comments are found below each post.
I am going to share with you how I manage my IRA and the power of reducing your cost basis. My goal each year is a 20% return in my IRA. Sometimes I make it and sometimes I don't, but I believe that all of my success is due to reducing my cost basis. To illustrate the power of reducing your cost basis here are some trades we did last year. These trades are taken from an educational portfolio we ran in a paper-trading account for a little more than a year.
We bought RIG on 5/15/2012 for $44.13, sold it on 1/18/2013 for $46 but booked a profit of $1,154.
We bought MT on 1/4/2012 for $19.24, sold it on 12/21/2012 for $15 but booked a profit of $454.
We bought CHK on 1/27/2012 for $21.93, sold it on 10/19/2012 for $18 b...
Stock market posts another record setting week, but the big news came after Friday’s close.
Courtesy of NASA
The stock market put on another record setting show with the Dow Jones Industrial Average (NYSEARCA:DIA) closing at a record high 15,118 and the S&P 500 (NYSEARCA:SPY) closing at 1633.70, another all time closing high.
For the week, the Dow Jones Industrial Average (NYSEARCA:DIA) gained 1%, the S&P 500 (NYSEARCA:SPY) climbed 1.2%, the Nasdaq Composite (NYSEARCA:...
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well, well, well....it is good to know that there are others in the scientific arena who believed that YMI Bioscience's data (cough - Gilead) is a better drug than Incyte's Jakafi. Now, the definitive data are still unknown, but there was enough evidence from a Phase 2 trial to take a small risk for a huge reward. So, let's forget about Apple (AAPL), and do nothing but biotechs from now until Congress passes universal health care coverage for prescriptions....and drive the prices down so that research and development is no longer feasible to conduct in the US. Even Seattle Genetics (SGEN) has been on a tear as of late...
Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither Philstockworld, LLC (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.